Skip to content


BMC Infectious Diseases

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Efficacy of a bivalent killed whole-cell cholera vaccine over five years: a re-analysis of a cluster-randomized trial

BMC Infectious DiseasesBMC series – open, inclusive and trusted201818:84

Received: 13 January 2017

Accepted: 29 January 2018

Published: 20 February 2018

Back to article

Open Peer Review reports

Pre-publication versions of this article are available by contacting

Original Submission
13 Jan 2017 Submitted Original manuscript
6 Feb 2017 Reviewed Reviewer Report - Tom Wierzba
4 Sep 2017 Reviewed Reviewer Report - Christian Herzog
3 Nov 2017 Reviewed Reviewer Report - Virginia Elizabeth Pitzer
13 Dec 2017 Author responded Author comments - Youyi Fong
Resubmission - Version 2
13 Dec 2017 Submitted Manuscript version 2
26 Jan 2018 Author responded Author comments - Youyi Fong
Resubmission - Version 3
26 Jan 2018 Submitted Manuscript version 3
29 Jan 2018 Editorially accepted
20 Feb 2018 Article published 10.1186/s12879-018-2981-4

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting

You can find further information about the peer review system here.

Authors’ Affiliations

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, USA
Department of Biostatistics, School of Public Health, University of Washington, Seattle, USA
Epidemiology Unit, International Vaccine Institute, Seoul, Republic of Korea
icddr,b, Dhaka, Bangladesh
Institute for Disease Modeling, Intellectual Ventures, Bellevue, USA
The Department of Medicine, The University of Cambridge, Cambridge, United Kingdom